Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer.
Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer.
复制标题
DOI:
10.1038/bjc.1988.16
复制
发表时间:
1988-01
影响因子:
8.8
通讯作者:
Millar, J L
中科院分区:
文献类型:
--
作者:
Macauly, V M;Teale, J D;Everard, M J;Joshi, G P;Smith, I E;Millar, J L
Rapid proliferation in small cell lung cancer (SCLC) may be mediated by synthesis of autocrine growth factors. Bombesin (or its mammalian homologue gastrin releasing peptide, GRP) may have autocrine function in SCLC (Cuttitta et al., 1985; Carney et al., 1987) but is not synthesised by the faster growing variant SCLC lines (Carney et al., 1985). Somatomedin-C (Sm-C)/insulin-like growth factor-I (IGF-I) is a basic peptide of 70 amino acids and MW 7.6 kD which is carried in serum by binding proteins of 40-150 kD (Underwood et al., 1986a). It derives mainly from the liver but also from extrahepatic sites including lung (D'Ercole et al., 1984). Function as an autocrine growth factor has been described in several cell systems, including cultured human fibroblasts (Clemmons et al., 1981) and breast carcinoma (Huff et al., 1986). Minuto et al (1986) reported high levels of Sm-C in operative specimens of primary lung tumour tissue. All 10 samples were adeno-or squamous carcinoma; no results were given for SCLC, presumably because these patients rarely come to surgery. Two more recent studies have reported expression by a human large cell lung cancer line of genes for multiple growth factors including IGF-II but not IGF-I (Betsholtz et al., 1987), and the presence of'insulin-like'molecules in SCLC conditioned medium (Cuttitta et al., 1987).We have been working with a high molecular weight (> 10 kD) concentrate of classic SCLC conditioned medium which is mitogenic to both classic and variant SCLC lines despite being depleted of bombesin/GRP (Macaulay et al., 1987). The concentrate was found to contain immunoreactive Sm-C, prompting a survey of human lung tissues and cell lines.